| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 441,824 shares worth roughly $17.0M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | - | - | |
| Dir | 448.0K | - | - | |
| Dir | 130.1K | - | - | |
| Dir | 127.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Mignone Roberto | Director | Sell | 519,000 | $17.03 | $8,838,570.00 | -34.6% | +6.2% | +0.3% | |
| May 16, 2024 | Weiss Amir | Chief Accounting Officer | Sell | 28,135 | $16.73 | $470,793.59 | -84.5% | +10.5% | +3.9% | |
| May 13, 2024 | Conway Vikki L | See "remarks" | Sell | 15,219 | $16.74 | $254,807.15 | -100% | +1.2% | +3.6% | |
| Mar 6, 2024 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sale+OE | 77,550 | $13.52 | $1,048,119.27 | -27.6% | +22.9% | +13.5% | |
| Mar 5, 2024 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 48,629 | $13.52 | $657,240.39 | -33.0% | +25.4% | +17.4% | |
| Mar 5, 2024 | Conway Vikki L | See "remarks" | Sale+OE | 1,427 | $13.52 | $19,286.48 | -8.6% | +25.4% | +17.4% | |
| Mar 5, 2024 | Sabag Mark | EVP, International Markets | Sale+OE | 100,000 | $13.52 | $1,352,090.00 | -20.7% | +25.4% | +17.4% | |
| Mar 4, 2024 | Conway Vikki L | See "remarks" | Sale+OE | 3,532 | $13.37 | $47,234.50 | -23.2% | +26.3% | +16.7% | |
| Mar 4, 2024 | Francis Richard D | President And CEO | Sale+OE | 31,061 | $13.34 | $414,269.88 | -20.1% | +26.3% | +16.7% | |
| Mar 4, 2024 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 95,762 | $13.34 | $1,277,206.52 | -57.9% | +26.3% | +16.7% |